Tag: Weight Loss
ADA: Once-Daily Semaglutide Superior for Reduction in Body Weight
Superior and clinically meaningful reduction in body weight in adults with overweight, obesity without type 2 diabetes
ADA: Once-Daily Orforglipron Linked to Significant Weight Reduction
Weight reduction of at least 10 percent occurred in 46 to 75 percent receiving orforglipron by week 36
Time-Restricted Eating More Effective for Weight Loss Than Control
However, weight loss by 12 months was not significantly different for time-restricted eating, calorie restriction
Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic
Company has moved to stop some medical spas, weight loss clinics, and compounding pharmacies from selling compounded versions of semaglutide
ASCO: Phone-Based Coaching Helps Breast Cancer Patients Lose Weight
Authors say next step in research is to see if weight loss impacts cancer recurrence
FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
Agency does not review compounded drugs for safety, effectiveness, or quality; compounded medications are not FDA-approved
Physicians Only Recognize One in Five Cases of Unintentional Weight Loss
Furthermore, authors say, diagnostic practices show variability
Maker of Wegovy Limits Supply of Obesity Drug in the United States
Wegovy is one of three glucagon-like peptide 1 drugs that are effective for weight loss but have faced shortages amid a boom in sales
Prediagnostic Weight Loss Underestimates Risk for Colorectal Cancer
Association for high BMI and colorectal cancer risk most pronounced using BMI at least eight years before diagnosis
Injected Diabetes Med Can Also Bring Big Weight Loss, Study Finds
Late-stage trial shows tirzepatide triggers more weight loss than semaglutide; however, results have not yet been peer-reviewed or published in a journal
